Updated on 15 June 2026
Ex vivo CAR-T treatment
Head of strategy at VIROXIS
PARIS, France
About
Viroxis, in collaboration with Institut Gustave Roussy, has developed and optimized a new CAR-T cells preparation process, without the standard activation which leads to exhaustion. We are looking for development partners
Stage
- Design - setting the project scope
Topic
- Next-generation therapeutics and modalities
Type
- Expertise offered
Organisation
Similar opportunities
Project cooperation
Seeking experts in translational biomarker development in oncology
- Design - setting the project scope
- Next-generation therapeutics and modalities
Andri Leonidou
Head of BI and Corporate Affairs at Nuage Therapeutics
Barcelona, Spain
Project cooperation
Seeking a partner with expertise in antibody production
- Project idea is seeking partners
- Design - setting the project scope
- Next-generation therapeutics and modalities
Andri Leonidou
Head of BI and Corporate Affairs at Nuage Therapeutics
Barcelona, Spain
Project cooperation
Nanoparticle-based drug/gene delivery systems
- Expertise offered
- Next-generation therapeutics and modalities
Paula Rodrigo
Innovation manager at IDM - Universitat de València at Instituto Interuniversitario de Reconocimiento Molecular y Desarrollo Tecnológico (IDM)
València, Spain